سعر روادينافيل 20مجم 4 اقراص 2026

Rowadinafil 20 mg film-coated tablets (pack of 4) contain vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction; listed in Egypt under Al Rowad Pharmaceutical Industrial Co.

• Treatment of erectile dysfunctionPopulation: Adult menDailyMed (U.S. National Library of Medicine)

• Adverse reactions reported in at least 2% of patients and more often than placebo include headache, flushing, rhinitis, dyspepsia and sinusitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Concomitant nitrates (regular or intermittent) or nitric oxide donors: may potentiate hypotension.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant guanylate cyclase stimulators such as riociguat.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Assess cardiovascular status before use; sexual activity carries cardiac risk in some patients.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Strong or moderate CYP3A4 inhibitors (e.g. ritonavir, indinavir, cobicistat, ketoconazole, erythromycin) raise vardenafil levels; dose adjustment required.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Erection lasting more than 4 hours or priapism needs immediate medical attention.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Nitrates / nitric oxide donorsContraindicated: potentiation of hypotensive effect.DailyMed (U.S. National Library of Medicine)
• Alpha-blockersAdditive blood-pressure lowering; caution, start alpha-blocker or vardenafil at the lowest dose in stable patients.DailyMed (U.S. National Library of Medicine)
• CYP3A4 inhibitors (ritonavir, indinavir, ketoconazole, itraconazole, clarithromycin, erythromycin)Increase vardenafil exposure; lower maximum vardenafil doses are required per the label.DailyMed (U.S. National Library of Medicine)

• Not indicated for use in females; no data in pregnant women; no adverse developmental outcomes in rat and rabbit studies.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not indicated for females; no information on presence in human milk; present in rat milk.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Vardenafil: Selective PDE5 inhibition enhances nitric oxide / cGMP-mediated smooth-muscle relaxation and erection during sexual stimulation (US label).